Heritage Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,938
Closed -$211K 128
2024
Q4
$211K Sell
7,938
-1,432
-15% -$38.8K 0.03% 111
2024
Q3
$271K Buy
9,370
+200
+2% +$5.83K 0.04% 86
2024
Q2
$257K Buy
9,170
+1,884
+26% +$51.9K 0.04% 86
2024
Q1
$202K Sell
7,286
-256
-3% -$7.1K 0.03% 104
2023
Q4
$217K Sell
7,542
-194
-3% -$5.87K 0.04% 93
2023
Q3
$257K Sell
7,736
-111
-1% -$3.92K 0.05% 64
2023
Q2
$288K Sell
7,847
-606
-7% -$23.6K 0.06% 62
2023
Q1
$345K Buy
8,453
+606
+8% +$26.2K 0.08% 58
2022
Q4
$402K Sell
7,847
-10,817
-58% -$519K 0.1% 53
2022
Q3
$816K Buy
18,664
+778
+4% +$37.8K 0.5% 25
2022
Q2
$937K Sell
17,886
-4,758
-21% -$242K 0.52% 18
2022
Q1
$1.17M Buy
22,644
+1,336
+6% +$69.3K 0.77% 17
2021
Q4
$1.26M Buy
+21,308
New +$1.06M 0.99% 15

Other funds holding PFE

Heritage Financial Services's PFE Position: Q1 2025 in Review

Heritage Financial Services sold out of Pfizer (PFE) in Q1 2025, closing a stake of 7,938 shares — an estimated $211K sold.

Heritage Financial Services first reported a position in PFE in Q4 2021 and held it in 13 quarters. The position peaked at $1.26M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Heritage Financial Services reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Heritage Financial Services sold 7,938 Pfizer shares in Q1 2025, an estimated $211K.
  • Heritage Financial Services first reported a position in Pfizer in Q4 2021 and held it in 13 quarters.
  • Heritage Financial Services's Pfizer position peaked at $1.26M in Q4 2021.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Heritage Financial Services's 13F filing for Q1 2025, filed 14 May 2025.